Drug intelligence / Profile preview

Colgate SNF

Development stage: Unknown
Lead developer: Colgate-Palmolive
Modality: Small Molecules
Administration: Topical

Overview

**Colgate SNF** is a Colgate-Palmolive investigational topical dentifrice containing stannous fluoride, evaluated for reducing dentinal hypersensitivity. Stannous fluoride provides fluoride for enamel remineralization and caries prevention while stannous ions can occlude exposed dentinal tubules, reducing fluid movement associated with sensitivity pain; stannous fluoride also has antimicrobial oral-health effects. The exact intervention name \"Colgate SNF\" was used in the completed Phase 3 trial NCT06244290, which compared it with Sensodyne Extra Whitening and a regular fluoride toothpaste for dentinal hypersensitivity. ([ichgcp.net](https://ichgcp.net/clinical-trials-registry/NCT06244290))

Other names: Colgate SNF

Beyond the preview

Go deeper on Colgate SNF.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colgate SNF.

Explore the full profile